Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Avoid GP Strategies Corporation (GPX)?

Page 1 of 2

In the financial world, there are a multitude of metrics shareholders can use to analyze stocks. A duo of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best money managers can trounce the market by a very impressive amount (see just how much).

GP Strategies Corporation (NYSE:GPX)

Just as key, positive insider trading sentiment is another way to analyze the financial markets. Obviously, there are plenty of incentives for a corporate insider to sell shares of his or her company, but only one, very simple reason why they would behave bullishly. Various academic studies have demonstrated the valuable potential of this method if investors know where to look (learn more here).

What’s more, we’re going to study the latest info for GP Strategies Corporation (NYSE:GPX).

What have hedge funds been doing with GP Strategies Corporation (NYSE:GPX)?

Heading into Q3, a total of 8 of the hedge funds we track were bullish in this stock, a change of -11% from the first quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists a few noteworthy hedge fund managers who were increasing their stakes considerably.

Out of the hedge funds we follow, Dan Friedberg’s Sagard Capital Partners Management Corp had the most valuable position in GP Strategies Corporation (NYSE:GPX), worth close to $83.6 million, accounting for 29.6% of its total 13F portfolio. On Sagard Capital Partners Management Corp’s heels is Manatuck Hill Partners, managed by Mark Broach, which held a $27.7 million position; 3.4% of its 13F portfolio is allocated to the company. Some other hedge funds that hold long positions include Chuck Royce’s Royce & Associates, Peter S. Park’s Park West Asset Management and Jim Simons’s Renaissance Technologies.

Judging by the fact that GP Strategies Corporation (NYSE:GPX) has faced a fall in interest from upper-tier hedge fund managers, it’s safe to say that there exists a select few hedge funds who sold off their positions entirely last quarter. It’s worth mentioning that Robert B. Gillam’s McKinley Capital Management dropped the biggest stake of all the hedgies we key on, totaling an estimated $3.1 million in stock, and Israel Englander of Millennium Management was right behind this move, as the fund dropped about $0.6 million worth. These transactions are interesting, as total hedge fund interest dropped by 1 funds last quarter.

How have insiders been trading GP Strategies Corporation (NYSE:GPX)?

Insider buying made by high-level executives is most useful when the company we’re looking at has experienced transactions within the past half-year. Over the latest 180-day time period, GP Strategies Corporation (NYSE:GPX) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll check out the relationship between both of these indicators in other stocks similar to GP Strategies Corporation (NYSE:GPX). These stocks are ITT Educational Services, Inc. (NYSE:ESI), Bridgepoint Education Inc (NYSE:BPI), Strayer Education Inc (NASDAQ:STRA), Capella Education Company (NASDAQ:CPLA), and Education Management Corp (NASDAQ:EDMC). This group of stocks are in the education & training services industry and their market caps resemble GPX’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!